Biontech Se ADR
(BNTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,035,260 | 14,618,810 | 13,520,350 | 9,934,094 | 6,917,353 |
| Marketable Securities | 384,277 | 199,552 | 4,835 | 106 | 1,010 |
| Receivables | 7,495,660 | 7,529,025 | 7,362,431 | 11,049,910 | 14,247,680 |
| Inventories | 455,229 | 463,163 | 296,923 | 391,306 | 515,427 |
| Other current assets | 189,994 | 286,471 | 237,402 | 130,043 | 163,391 |
| TOTAL | $21,560,420 | $23,097,020 | $21,421,940 | $21,505,460 | $21,844,860 |
| Non-Current Assets | |||||
| PPE Net | 686,117 | 641,853 | 492,017 | 447,390 | 402,084 |
| Investments And Advances | 554,733 | 84,499 | 53,180 | 54,806 | 54,315 |
| Intangibles | 406,389 | 231,476 | 227,829 | 235,614 | 242,395 |
| Other Non-Current Assets | 491,939 | 472,013 | 628,795 | 270,307 | 236,560 |
| TOTAL | $2,139,179 | $1,429,841 | $1,401,821 | $1,008,117 | $935,354 |
| Total Assets | $23,699,600 | $24,526,860 | $22,823,760 | $22,513,580 | $22,780,210 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 40,145 | 37,930 | 37,266 | 34,374 | 34,339 |
| Accounts payable and accrued liabilities | 32,095 | 215,040 | 298,635 | 309,789 | 138,816 |
| Other current liabilities | 1,027,566 | 2,227,943 | 2,252,804 | 2,322,510 | 2,341,134 |
| TOTAL | $1,664,736 | $3,108,752 | $3,986,196 | $4,175,602 | $4,325,520 |
| Non-Current Liabilities | |||||
| Long Term Debt | 185,054 | 185,644 | 238,706 | 219,864 | 174,390 |
| Other Non-Current Liabilities | 91,346 | 95,351 | 93,267 | 100,035 | 368,194 |
| TOTAL | $282,090 | $287,527 | $339,024 | $426,744 | $599,704 |
| Total Liabilities | $1,946,826 | $3,396,280 | $4,325,219 | $4,602,346 | $4,925,224 |
| Shareholders' Equity | |||||
| Common Shares | 266,847 | 261,925 | 250,390 | 264,560 | 276,959 |
| Retained earnings | 20,754,400 | 19,842,450 | 16,673,490 | 15,717,600 | 15,241,380 |
| Other shareholders' equity | -921,993 | -893,987 | 526,697 | 136,785 | 122,847 |
| TOTAL | $21,752,770 | $21,130,580 | $18,498,540 | $17,911,230 | $17,854,990 |
| Total Liabilities And Equity | $23,699,596 | $24,526,860 | $22,823,759 | $22,513,576 | $22,780,214 |